Putative novel CSF biomarkers of Alzheimer's disease based on the novel concept of generic protein m...
Putative novel CSF biomarkers of Alzheimer's disease based on the novel concept of generic protein misfolding and proteotoxicity: the PRAMA cohort
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
In this spectrum, seven biomarkers have attained widely recognized diagnostic relevance, including low levels of the 42-residue amyloid beta (Aβ42) and high concentrations of total tau (T-tau) and phosphorylated tau (P-tau) in the cerebrospinal fluid (CSF), high cortical amyloid deposition and tau deposition measured with positron emission tomograp...
Alternative Titles
Full title
Putative novel CSF biomarkers of Alzheimer's disease based on the novel concept of generic protein misfolding and proteotoxicity: the PRAMA cohort
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_47ee1919563b4474a43a02c85f006f48
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_47ee1919563b4474a43a02c85f006f48
Other Identifiers
ISSN
2047-9158
E-ISSN
2047-9158
DOI
10.1186/s40035-024-00405-0
